ERBB2 and breast carcinoma: At the molecular level, DNMT1 overexpression promotes hypermethylation of tumor suppressor gene promoters (including ERα and BRCA1), which leads to their silencing and enhances breast cancer aggressiveness, particularly in ER-negative and HER2-positive tumors.